• Search
  • Helpdesk
  • Sales contact

Biotech and eCOA vendor: A shared mindset

Last updated: July 3, 2025

Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they are operating under tremendous pressure due to time and cost constraints, limited internal resources, and the substantial impact of each clinical trial project. These specific challenges demand trusted partners for clinical trial success.

Kayentis understands these challenges and is committed to being a trusted partner for biotechs.


Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

November 4 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to...